Delivery Order SPE2DB20D1004-SPE2DB24FG2J7

Award Date 6/13/24
Potential Completion Date 6/14/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,016.35, is for the supply of MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract is a Firm Fixed Price, Delivery Order type and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order valued at $1,181.45 for the provision of MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract has a completion date of June 4, 2024 and is a Firm Fixed Price arrangement. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,023.61, is for the delivery of MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of June 5, 2024. The contract is not designated as a set-aside....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,300.50 and is a firm fixed-price contract for the delivery of MESALAMINE DR 1.2 GM TABLET 120S, a medical product. The contract has an ultimate completion date of February 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,594.32 Firm Fixed Price delivery order is for the supply of 4566550847 MESALAMINE DR 1.2 GM TABLET 120S. The contract has an ultimate completion date of November 27, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $16,619.34, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560160504 MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product. This award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,048.56, is a Firm Fixed Price Delivery Order to provide MESALAMINE DR 1.2 GM TABLET 120S medical supplies. The contract has an ultimate completion date of February 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $4,040.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MESALAMINE DR 1.2 GM TABLET 120S, a medical product, and is a Firm Fixed Price Delivery Order with an ultimate completion date of March 14, 2025. The contract was not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of MESALAMINE DR 1.2 GM TABLET 120S. The $1,621.24 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 3, 2025. The contract is a delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract, valued at $1,165.58, is for the supply of 4565310175 MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract is a Firm Fixed Price, Delivery Order contract type with an ultimate completion date of August 1, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FG2J7
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,453.14, is for the supply of MESALAMINE DR 1.2 GM TABLET 120S, a generic pharmaceutical product. The contract has a completion date of June 14, 2024, and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not utilize any set-aside designations, indicating open competition.

Generated 5/17/25, 10:12 AM